Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.
Watson E, Shinkins B, Frith E, Neal D, Hamdy F, Walter F, Weller D, Wilkinson C, Faithfull S, Wolstenholme J, Sooriakumaran P, Kastner C, Campbell C, Neal R, Butcher H, Matthews M, Perera R, Rose P. Watson E, et al. Among authors: sooriakumaran p. BJU Int. 2016 Jun;117(6B):E10-9. doi: 10.1111/bju.13122. Epub 2015 May 23. BJU Int. 2016. PMID: 25818406 Free article.
Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV).
Watson EK, Shinkins B, Matheson L, Burns RM, Frith E, Neal D, Hamdy F, Walter FM, Weller D, Wilkinson C, Faithfull S, Sooriakumaran P, Kastner C, Campbell C, Neal RD, Butcher H, Matthews M, Perera R, Wolstenholme J, Rose PW. Watson EK, et al. Among authors: sooriakumaran p. Eur J Oncol Nurs. 2018 Feb;32:73-81. doi: 10.1016/j.ejon.2017.12.002. Epub 2017 Dec 29. Eur J Oncol Nurs. 2018. PMID: 29353635
PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial.
Watson E, Rose P, Frith E, Hamdy F, Neal D, Kastner C, Russell S, Walter FM, Faithfull S, Wolstenholme J, Perera R, Weller D, Campbell C, Wilkinson C, Neal R, Sooriakumaran P, Butcher H, Matthews M. Watson E, et al. Among authors: sooriakumaran p. BMJ Open. 2014 May 22;4(5):e005186. doi: 10.1136/bmjopen-2014-005186. BMJ Open. 2014. PMID: 24852301 Free PMC article. Clinical Trial.
Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo-Metastases to the bone (TRoMbone) trial.
Sooriakumaran P, Wilson C, Rombach I, Hassanali N, Aning J, D Lamb A, Cathcart P, Eden C, Ahmad I, Rajan P, Sridhar A, Bryant RJ, Elhage O, Cook J, Leung H, Soomro N, Kelly J, Nathan S, Donovan JL, Hamdy FC. Sooriakumaran P, et al. BJU Int. 2022 Jul;130(1):43-53. doi: 10.1111/bju.15669. Epub 2022 Jan 27. BJU Int. 2022. PMID: 34878715 Free article. Clinical Trial.
Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?
Bryant RJ, Yang B, Philippou Y, Lam K, Obiakor M, Ayers J, Chiocchia V, Gleeson F, MacPherson R, Verrill C, Sooriakumaran P, Hamdy FC, Brewster SF. Bryant RJ, et al. Among authors: sooriakumaran p. BJU Int. 2018 Nov;122(5):794-800. doi: 10.1111/bju.14248. Epub 2018 May 9. BJU Int. 2018. PMID: 29645347
Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
Hamdy FC, Elliott D, le Conte S, Davies LC, Burns RM, Thomson C, Gray R, Wolstenholme J, Donovan JL, Fitzpatrick R, Verrill C, Gleeson F, Singh S, Rosario D, Catto JW, Brewster S, Dudderidge T, Hindley R, Emara A, Sooriakumaran P, Ahmed HU, Leslie TA. Hamdy FC, et al. Among authors: sooriakumaran p. Health Technol Assess. 2018 Sep;22(52):1-96. doi: 10.3310/hta22520. Health Technol Assess. 2018. PMID: 30264692 Free PMC article. Clinical Trial.
Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer.
Elliott D, Hamdy FC, Leslie TA, Rosario D, Dudderidge T, Hindley R, Emberton M, Brewster S, Sooriakumaran P, Catto JWF, Emara A, Ahmed H, Whybrow P, le Conte S, Donovan JL. Elliott D, et al. Among authors: sooriakumaran p. BJU Int. 2018 Dec;122(6):970-977. doi: 10.1111/bju.14432. Epub 2018 Aug 15. BJU Int. 2018. PMID: 29888845 Free PMC article.
183 results